CFO of Goleta’s Resonant leaves company
Goleta-based Resonant, a designer of filters for radio frequency front-ends, announced July 29 that John Philpott, the company’s chief financial officer, has left the company for personal reasons. Ross Goolsby of Bridgepoint Consulting will join the company Aug. 1 and will become interim CFO after the company files its form 10-Q for the second quarter. Read More →
PG&E replacing Diablo Canyon power won’t be easy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MindBody reports revenue increase, narrows loss in second quarter
San Luis Obispo-based software firm MindBody substantially narrowed its loss for the second quarter, an indication the company’s plan to reach profitability is on track. The company said July 27 that its revenue jumped 36 percent to $33.6 million as its loss, using generally accepted accounting principles or GAAP, narrowed to $6.6 million or 16 Read More →
Certification gives Apeel appeal
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen wins one, loses one in biosimilar battle
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA panel recommends Amgen biosimilar drug for approval
A Food and Drug Administration panel recommended an Amgen biosimilar drug for approval July 12, just days after it said the biosimilar performed like a drug it mimicked. ABP 501, made by Thousand Oaks biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and Read More →
Goleta’s Resonant buys GVR Trade SA for $1.1 million
Resonant, a late stage Goleta development company designing small smartphone technology, announced it bought Switzerland-based GVR Trade SA on July 8 for $1.1 million in stock and cash. Resonant designs a smartphone component called a duplexer. The duplexer acts as a phone’s eyes. A set of filters inside the duplexer selects which radio frequencies to Read More →
